Study checks radiation effects in colon cancer lung-limited spread
Part of Cancer clinical trials.
This trial studies how targeted radiation (SBRT) affects cancer biology and immune cells in people with colon cancer that has spread only to a small number of lung nodules. Your tumor tissue will be analyzed to see what changes after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with colorectal adenocarcinoma (a type of colon cancer)
- You have 2 or 3 lung nodules, each smaller than 25 mm, and you currently feel well (no symptoms from them)
- You can do usual daily activities fairly well (ECOG 0 or 1)
- You can have SBRT (a clinician decides you are a candidate for this targeted radiation)
- You have tumor tissue available from a past surgery/biopsy (FFPE tissue block)
- You can and agree to follow-up visits, and you provide informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two treatments for lung spots that have spread from colorectal cancer: surgery to remove them versus a precise type of radiation (called stereotactic ablative radiotherapy). It aims to find out which approach offers better control and quality of life for patients like you.
This trial studies giving targeted high-dose radiation (SBRT) to liver metastases from colorectal cancer after initial treatment, with the goal of improving long-term control or cure. It may help people who have a limited number of liver spots that doctors think can be treated safely and effectively.
This trial tests combining focused radiation (SBRT) with immunotherapy for colorectal cancer that has spread to the liver or lungs. The goal is to see if this combination can shrink tumors and improve control of the cancer.
This trial combines targeted radiation (SBRT) with an immunotherapy drug (PD-1 inhibitor) to treat colorectal cancer that has spread to the liver and can't be removed by surgery. It aims to help shrink or control tumors in patients whose cancer has a normal DNA repair system (pMMR/MSS).
This trial tests whether a precise type of radiation called SBRT can control lung cancer that has started to grow in only a few new spots while you are on standard treatments. It may help you delay changing to a different treatment.
This trial tests whether focused radiation (SBRT) can treat 1 to 3 metastases in people with colorectal cancer that has spread but is still low or intermediate risk. It may be an option if you are starting first or second line systemic therapy and your primary tumor is under control.
Hear when a new Colorectal Cancer Metastatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.